EX-FILING FEES 31 d541146dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

FORM S-1

(Form Type)

Aeglea BioTherapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price
Per Unit		   Maximum
Aggregate
Offering Price		   Fee Rate   Amount of
Registration
Fee		   Carry
Forward
Form
Type		   Carry
Forward
File
Number		   Carry
Forward
Initial
effective
date		   Filing Fee
Previously
Paid
In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

   Equity  

Common stock,
par value
$0.0001

per share(1)

   Rule 457(c)   18,809,064(2)   $8.96(3)   $168,529,213.44(3)   0.0001476   $24,874.91          
 
Carry Forward Securities
                         

Carry

Forward

Securities

   N/A   N/A   N/A   N/A     N/A       N/A   N/A   N/A   N/A
                   
    Total Offering Amounts      $     $24,874.91          
                   
    Total Fees Previously Paid          $60,570.57(4)          
                   
    Total Fee Offsets          —            
                   
    Net Fee Due                $0                

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers such an indeterminate amount of shares of common stock as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events.

(2)

The amount registered consists of up to (i) 8,864 shares of Common Stock, and (ii) 18,800,200 shares of Common Stock issuable upon the conversion of 470,005 shares of Series A Preferred Stock.

(3)

Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Capital Market on November 10, 2023 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).

(4)

The registrant previously paid $60,570.57 in connection with the initial filing of this registration statement on Form S-1 (333-273769) originally filed on Form S-3 with the Securities and Exchange Commission on August 7, 2023.